DOI: 10.12890/2021_002661
When Should Statins Be Stopped?
Authors
mariob@campus.ul.pt
Keywords
Mycobacterium chelonae, statin-induced rhabdomyolysis, ciprofloxacin, clarithromycinAbstract
Mycobacterium chelonae is a non-tuberculous mycobacterium that can cause skin infections in immunocompetent individuals. We report a case of skin infection by this agent in a woman with dyslipidaemia, that culminated in statin-induced rhabdomyolysis due to the combination of clarithromycin, ciprofloxacin and simvastatin.
References
- Uslu U, Böhm O, Heppt F, Sticherling M. Skin and soft tissue infections caused by Mycobacterium chelonae: more common than expected? Acta Derm Venereol 2019;99(10):889–893.
- Cabral BMI, Edding SN, Portocarrero JP, Lerma EV. Rhabdomyolysis. Dis Mon 2020;66(8):101015.
- Wiggins BS, Saseen JJ, Page RL 2nd, Reed BN, Sneed K, Kostis JB, et al; American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Hypertension; Council on Quality of Care and Outcomes Research; and Council on Functional Genomics and Translational Biology. Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2016;134(21):e468–e495.
- Patel AM, Shariff S, Bailey DG, Juurlink DN, Gandhi S, Mamdani M, et al. Statin toxicity from macrolide antibiotic coprescription: a population-based cohort study. Ann Intern Med 2013;158(12):869–876.
- Goldie FC, Brogan A, Boyle JG. Ciprofloxacin and statin interaction: a cautionary tale of rhabdomyolysis. BMJ Case Rep 2016;2016:bcr2016216048.
Published
2021-06-15
Issue
How to Cite
1.
Bibi M, Ferro A, Guimarães F, Coelho P, Chora I. When Should Statins Be Stopped? EJCRIM [Internet]. 2021 Jun. 15 [cited 2026 Nov. 3];8(6). Available from: https://ejcrim.com/index.php/ejcrim/article/view/2661
